Gossamer Bio announces $250m in funding to advance seralutinib
finance.yahoo.com
24.08.2026 12:15
55 views
Related stories
The AI boom is starting to break time-tested stock-market signals
marketwatch.com · 28.10
Workers should be able to know colleagues' salaries, rights body says
bbc.co.uk · 28.10
The real way to tell if Amazon’s AI spending is paying off
marketwatch.com · 28.10
What do you want from the Budget?
bbc.co.uk · 28.10
EU's 'Made in Europe' push unnerves global auto suppliers
dw.com · 28.10
Four reasons to start worrying about inflation — including the end of tariff refunds
marketwatch.com · 28.10